Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study
{{output}}
Large granular lymphocytic leukemia (LGLL) is characterized by the clonal proliferation of cytotoxic T lymphocytes or NK cells. Standard first-line immunosuppressive treatments have limitations, achieving complete remission (CR) rates of up to 50%. Immune syst... ...
